Bojun Wang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Epigenetics and DNA Methylation 4
- Ubiquitin and proteasome pathways 2
- Circular RNAs in diseases 2
- Cancer-related gene regulation 2
- Oncology 11
- Cancer Immunotherapy and Biomarkers 4
- Cancer-related Molecular Pathways 2
- Co-authors
- Guoliang Ye (4 shared papers)Yongfu Shao (3 shared papers)Xinjun Zhang (2 shared papers)Xisong Ke (3 shared papers)Yi Qu (3 shared papers)Min Miao (2 shared papers)Lijun Qin (1 shared paper)Qier Li (1 shared paper)
In The Last Decade
Bojun Wang
32 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 85
- Cancer Research 391
- Oncology 262
- Molecular Biology 623
- Immunology 177
- Pathology and Forensic Medicine 65
Countries citing papers authored by Bojun Wang
This map shows the geographic impact of Bojun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bojun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bojun Wang more than expected).
Fields of papers citing papers by Bojun Wang
This network shows the impact of papers produced by Bojun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bojun Wang. The network helps show where Bojun Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Bojun Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 355 | |
| 2 | 2021 | 185 | |
| 3 | 2018 | 165 | |
| 4 | 2017 | 44 | |
| 5 | 2016 | 42 | |
| 6 | 2019 | 41 | |
| 7 | 2022 | 34 | |
| 8 | 2023 | 30 | |
| 9 | 2024 | 29 | |
| 10 | 2022 | 29 | |
| 11 | 2020 | 24 | |
| 12 | 2024 | 24 | |
| 13 | 2020 | 22 | |
| 14 | 2023 | 17 | |
| 15 | 2020 | 16 | |
| 16 | 2016 | 15 | |
| 17 | 2024 | 14 | |
| 18 | 2023 | 13 | |
| 19 | 2019 | 11 | |
| 20 | 2021 | 11 |
About Bojun Wang
Bojun Wang is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Immunology, having authored 35 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Epigenetics and DNA Methylation (4 papers), Ubiquitin and proteasome pathways (2 papers), Cancer, Lipids, and Metabolism (2 papers), Circular RNAs in diseases (2 papers), Cancer-related Molecular Pathways (2 papers), Helicobacter pylori-related gastroenterology studies (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Cancer Research (391 citations), Oncology (262 citations), Molecular Biology (623 citations), Immunology (177 citations) and Pathology and Forensic Medicine (65 citations). Bojun Wang has collaborated with scholars based in China, Germany and Norway. Frequent co-authors include Guoliang Ye, Yongfu Shao, Xinjun Zhang, Xisong Ke, Yi Qu, Min Miao, Lijun Qin, Qier Li, Bingxiu Xiao and Junming Guo. Their work appears in journals such as Scientific Reports, Journal of Cancer, Cancer Letters, Cell Death and Differentiation and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.